© Reuters.
Chemed Corporation (NYSE: NYSE:), the Cincinnati-based parent company of VITAS Healthcare and Roto-Rooter, announced its 210th consecutive quarterly cash dividend on Friday. The 40-cent per share payout, which mirrors the dividend paid in September 2023, will be payable on December 4, 2023, to shareholders registered by November 13, 2023.
This consistent dividend payout continues Chemed’s tradition since it became a public company 52 years ago. The company’s representative, David P. Williams, made the announcement and also cautioned about the inherent risks associated with forward-looking statements.
Chemed operates two major subsidiaries. VITAS Healthcare is the largest end-of-life hospice care provider in the U.S., and Roto-Rooter is a nationwide leader in plumbing and drain cleaning services. Further information about Chemed and its operations can be found on the company’s website.
InvestingPro Insights
The InvestingPro data and tips indicate a positive outlook for Chemed Corporation. The company’s market cap stands at a robust 8800M USD, and the P/E Ratio (Adjusted) for Q3 2023 is 34.23, suggesting a high earnings multiple. Moreover, the company has exhibited a solid revenue growth of 4.5% over the last twelve months as of Q3 2023.
InvestingPro Tips further bolsters this positive perspective. The company’s revenue growth has been accelerating, and it yields a high return on invested capital. Furthermore, Chemed’s strong earnings should allow the management to continue its tradition of dividend payments, which it has done for 53 consecutive years. This is particularly noteworthy given the company’s recent announcement of its 210th consecutive quarterly cash dividend.
InvestingPro provides a wealth of additional tips and data for those interested in a deeper dive into Chemed Corporation’s performance. For instance, it offers insights into the company’s stock volatility, return on assets, and much more. With InvestingPro, investors have access to 20 additional tips and a comprehensive set of real-time metrics, all designed to aid in making informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
